Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum]

Authors Fragoulakis V, Raptis E, Vitsou E, Maniadakis N, Apostolopoulos V

Received 2 February 2015

Accepted for publication 2 February 2015

Published 17 March 2015 Volume 2015:7 Pages 161—162

DOI https://doi.org/10.2147/CEOR.S82058



Vassilis Fragoulakis,1 Efklidis Raptis,2 Elli Vitsou,2 Nikolaos Maniadakis1

1Health Services Organization and Management, National School of Public Health, 2Pfizer Hellas, Athens, Greece
 
The authors apologize that the following errors appear in their paper:
• Page 75, right column, line 29, citation 39 should be 38
• Page 76, left column, line 30, citations 40,41 should be 39,40
• Page 76, left column, line 32, citation 42 should be 41
• Page 76, left column, line 40, citation 43 should be 42
• Page 76, right column, line 12, citations 2,44–46 should be 2,43–45
• Page 78, left column, line 38, citation 47 should be 46
• Page 78, right column, line 3, citations 15,48–52 should be 15,47–51
• Page 78, right column, line 9, citation 53 should be 52
• Page 78, right column, line 18, citation 54 should be 53
• Page 78, right column, line 21, citation 55 should be 63
• Page 79, left column, line 31, citations 56–60 should be 54–59
• Page 79, left column, line 35, citations 51,61–63 should be 50,60–62
 
Read the original article

Creative Commons License © 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.